Hydrochloric Acid → 2-[1-(2-Hydroxybenzoyl)piperidin-4-yl]-5-(7-methoxy-2,2-dimethyl-2,3-dihydro-1-benzofuran-4-yl)-4,4-dimethyl-2,4-dihydro-3H-pyrazol-3-one
Reaktionsgleichung
C([O:4][C:5]1[CH:10]=[CH:9][CH:8]=[CH:7][C:6]=1[C:11]([N:13]1[CH2:18][CH2:17][CH:16]([N:19]2[C:23](=[O:24])[C:22]([CH3:26])([CH3:25])[C:21]([C:27]3[C:32]4[CH2:33][C:34]([CH3:37])([CH3:36])[O:35][C:31]=4[C:30]([O:38][CH3:39])=[CH:29][CH:28]=3)=[N:20]2)[CH2:15][CH2:14]1)=[O:12])(=O)C.[OH-].[K+].Cl>CO>[OH:4][C:5]1[CH:10]=[CH:9][CH:8]=[CH:7][C:6]=1[C:11]([N:13]1[CH2:14][CH2:15][CH:16]([N:19]2[C:23](=[O:24])[C:22]([CH3:25])([CH3:26])[C:21]([C:27]3[C:32]4[CH2:33][C:34]([CH3:36])([CH3:37])[O:35][C:31]=4[C:30]([O:38][CH3:39])=[CH:29][CH:28]=3)=[N:20]2)[CH2:17][CH2:18]1)=[O:12]Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
0.15 g 2-({4-[3-(7-methoxy-2,2-dimethyl-2,3-dihydro-1-benzofuran-4-yl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}carbonyl)phenyl acetate (compound described in example 77) are dissolved in 20 ml of methanol, 0.32 ml 1 M methanolic potassium hydroxide solution are added, and the reaction mixture is stirred at RT for 15 min until the reaction is completed according to TLC analysis. The pH is adjusted to 5.5 with 1 M aqueous hydrochloric acid, the solvents are removed under reduced pressure, and the resulting crude product is purified by column chromatography (silica and DCM/methanol=95:5) to yield the title compound.
Aufarbeitung
- customthe solvents are removed under reduced pressure
- customthe resulting crude product is purified by column chromatography (silica and DCM/methanol=95:5)
Quellen und Nachweise
- ORD-Eintrag
- ord-c1a1d44306b1411da3e6300d0507378b
- Quelldatensatz
- uspto-grants-2016_05
- Patentnummer
- US09340522B2
Notizen zur Reaktion
Wird geladen…